healthprotocol.wiki

medication-omalizumab

Outcomes

01
oncology-overall-response-rate-percent
2 evidence rows
- broesby-olsen_2018_cohort_omalizumab-prevents-anaphylaxis-and-improves-symptoms-in-systemic-mastocytosis
- lemal_2019_cohort_omalizumab-therapy-for-mast-cell-mediator-symptoms-in-patients-with-ism-cm-mmas-and-mcas